ATE196649T1 - Ein mutiertes crp-protein und verfahren und mittel zu dessen herstellung und verwendung - Google Patents
Ein mutiertes crp-protein und verfahren und mittel zu dessen herstellung und verwendungInfo
- Publication number
- ATE196649T1 ATE196649T1 AT94909837T AT94909837T ATE196649T1 AT E196649 T1 ATE196649 T1 AT E196649T1 AT 94909837 T AT94909837 T AT 94909837T AT 94909837 T AT94909837 T AT 94909837T AT E196649 T1 ATE196649 T1 AT E196649T1
- Authority
- AT
- Austria
- Prior art keywords
- unmutated
- amino acid
- crp
- precrp
- subunit
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 102000008300 Mutant Proteins Human genes 0.000 abstract 8
- 108010021466 Mutant Proteins Proteins 0.000 abstract 8
- 108010074051 C-Reactive Protein Proteins 0.000 abstract 6
- 102100032752 C-reactive protein Human genes 0.000 abstract 6
- 150000001413 amino acids Chemical class 0.000 abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4737—C-reactive protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2395293A | 1993-02-26 | 1993-02-26 | |
| PCT/US1994/002181 WO1994018999A1 (en) | 1993-02-26 | 1994-02-24 | A mutant protein and methods and materials for making and using it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE196649T1 true ATE196649T1 (de) | 2000-10-15 |
Family
ID=21818104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94909837T ATE196649T1 (de) | 1993-02-26 | 1994-02-24 | Ein mutiertes crp-protein und verfahren und mittel zu dessen herstellung und verwendung |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0688224B1 (de) |
| JP (1) | JPH08507212A (de) |
| AT (1) | ATE196649T1 (de) |
| AU (1) | AU6252294A (de) |
| DE (1) | DE69426018T2 (de) |
| ES (1) | ES2152976T3 (de) |
| WO (1) | WO1994018999A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100107263A1 (en) * | 2007-01-20 | 2010-04-29 | Boehringer Ingelheim International Gmbh & Co., Kg | C-reactive protein (crp) knockout mouse |
| EA034692B1 (ru) * | 2014-03-31 | 2020-03-06 | Бёрингер Ингельхайм Ветмедика Гмбх | Улучшенные транспортные молекулы модулярного антигена и их применение |
| JP2018527395A (ja) | 2015-09-30 | 2018-09-20 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハーＢｏｅｈｒｉｎｇｅｒ Ｉｎｇｅｌｈｅｉｍ Ｖｅｔｍｅｄｉｃａ ＧｍｂＨ | 改良モジュール型抗原移送分子及び動物におけるその使用 |
| CN115785193B (zh) * | 2022-11-25 | 2023-11-21 | 天津鸿宇泰生物科技有限公司 | 一种用于包涵体蛋白复性的复性缓冲液以及方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68925899T2 (de) * | 1988-04-04 | 1996-10-02 | Byron E Anderson | Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen |
-
1994
- 1994-02-24 AU AU62522/94A patent/AU6252294A/en not_active Abandoned
- 1994-02-24 AT AT94909837T patent/ATE196649T1/de not_active IP Right Cessation
- 1994-02-24 EP EP94909837A patent/EP0688224B1/de not_active Expired - Lifetime
- 1994-02-24 JP JP6519333A patent/JPH08507212A/ja active Pending
- 1994-02-24 DE DE69426018T patent/DE69426018T2/de not_active Expired - Fee Related
- 1994-02-24 WO PCT/US1994/002181 patent/WO1994018999A1/en not_active Ceased
- 1994-02-24 ES ES94909837T patent/ES2152976T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69426018D1 (de) | 2000-11-02 |
| WO1994018999A1 (en) | 1994-09-01 |
| ES2152976T3 (es) | 2001-02-16 |
| AU6252294A (en) | 1994-09-14 |
| EP0688224A4 (de) | 1997-09-10 |
| JPH08507212A (ja) | 1996-08-06 |
| DE69426018T2 (de) | 2001-02-22 |
| EP0688224B1 (de) | 2000-09-27 |
| EP0688224A1 (de) | 1995-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE400651T1 (de) | Verwendung von grünem fluoreszenzprotein | |
| DE69434578D1 (de) | Expressionsvektoren die für bispezifische Proteine kodieren, und Verfahren zur Herstellung von biologisch-aktiven bispezifischen Fusionsproteine in Zellen von Säugertieren | |
| EP0804609A4 (de) | NEUARTIGE AUF p53 ANSPRECHENDE GENE | |
| DE69839553D1 (de) | Verfahren zur herstellung von proteinen | |
| HUP9900018A1 (hu) | Cirkuláris DNS-molekula feltételes replikációs origóval, eljárás előállítására és génterápiában való felhasználására | |
| ATE91716T1 (de) | Verfahren zur herstellung vielkettige polypeptide oder proteine. | |
| DE60228477D1 (de) | Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins | |
| DE68921364D1 (de) | Verfahren zur Herstellung von Proteinen mittels rekombinanter DNA. | |
| DE60137847D1 (de) | Eg-vegf nukleinsäuren und polypeptide und verfahren zur deren verwendung | |
| AU6063500A (en) | Glycoprotein vi and uses thereof | |
| AR007225A1 (es) | Molecula mutante ctla4 soluble; proteina de fusion ctla4ig mutante soluble reactiva con el antigeno cd86 y proteina receptora ctla4 mutante soluble quela comprenden; codificacion de molecula de acido nucleico y cdna que la expresan; plasmido que comprende a este ultimo; metodo para producir una | |
| ATE301716T1 (de) | Vmp-ähnliche sequenzen von pathogener borrelia | |
| ATE521695T1 (de) | Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie | |
| ATE135371T1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
| ATE320484T1 (de) | Histone-deacetylase-8 proteine, nukleinsäuren und methoden zur verwendung | |
| ATE498013T1 (de) | Für zellzyklusproteine kodierende nukleinsäure und deren verwendung | |
| BR0016432A (pt) | Molécula de ácido nucleico isolada, vetor, célula hospedeira, descendentes, sementes ou material celular reproduzìvel, método de produção de um ou mais polipeptìdeo(s), tcmrp isolada, polipeptìdeo isolado, anticorpo, kit de teste, método para produzir um produto quìmico fino, produto quìmico fino, e, uso de um produto quìmico fino ou de polipeptìdeo(s). | |
| ATE310085T1 (de) | Cyclin-e2 proteine und dafür kodierende gene | |
| ATE196649T1 (de) | Ein mutiertes crp-protein und verfahren und mittel zu dessen herstellung und verwendung | |
| ATE346919T1 (de) | Nebenhoden-spezifisches rezeptorprotein und dessen verwendung | |
| ATE409746T1 (de) | Neuer spannungsabhängiger kaliumkanal und seine verwendung zur entwicklung von therapeutika | |
| ATE547427T1 (de) | Verfahren zur rekombinanten herstellung von ribonukleoproteinen | |
| Tong | Tuesday, November 6, 2007 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |